
1. General Information
Acabrunat 100 mg Capsule is an oral targeted cancer therapy containing acalabrutinib. Unlike traditional cytotoxic chemotherapy, acalabrutinib specifically targets BTK, a protein involved in B-cell receptor signaling and the growth and survival of certain malignant B cells.
It is used under the supervision of an oncologist/hematologist and requires appropriate clinical and laboratory monitoring during treatment.
Key information:
- Brand: Acabrunat
- Active ingredient: Acalabrutinib
- Strength: 100 mg
- Dosage form: Capsule
- Therapeutic class: Antineoplastic / targeted therapy
- Drug class: Bruton’s tyrosine kinase (BTK) inhibitor
- Manufacturer: Natco Pharma Ltd.
- Common pack: 30 capsules
2. Product Information
Acabrunat 100 mg is formulated for oral administration. Acalabrutinib selectively inhibits BTK, which plays an important role in B-cell signaling. By interfering with this pathway, the medicine can inhibit signaling that supports the proliferation and survival of malignant B cells.
The product should be stored according to the manufacturer's labeling and kept away from children. It should remain in its original packaging unless a pharmacist or healthcare professional provides other instructions.
3. Uses of Acabrunat 100 mg
Acalabrutinib is used for certain types of B-cell blood cancers, including:
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- Mantle cell lymphoma (MCL) in appropriately indicated patients, including those who have received prior therapy depending on the applicable treatment guidance.
The exact indication and treatment regimen should be determined by the treating specialist.
4. Benefits of Acabrunat 100 mg
The potential therapeutic benefits of acalabrutinib include:
- Provides targeted inhibition of BTK.
- Helps interfere with signaling pathways that support malignant B-cell survival and growth.
- Can help control certain B-cell malignancies and slow disease progression.
- Offers a targeted oral treatment option for eligible patients with CLL, SLL, or MCL.
The response varies between patients, and treatment benefits should be assessed through clinical evaluation and appropriate investigations.
5. Side Effects of Acabrunat 100 mg
Acalabrutinib can cause side effects, and some may require medical attention. Reported adverse effects include:
- Anemia
- Neutropenia
- Thrombocytopenia
- Upper respiratory tract infections
- Headache
- Diarrhea
- Musculoskeletal pain
- Fatigue
- Nausea
More serious risks can include bleeding, infections, low blood-cell counts, and certain heart-related problems.
Seek prompt medical attention for significant or unusual bleeding, severe infection symptoms, or other serious symptoms.
6. Common Side Effects
Some commonly reported side effects include:
- Headache
- Diarrhea
- Muscle or joint pain
- Fatigue
- Nausea
- Anemia
- Reduced neutrophil count
- Reduced platelet count
- Upper respiratory tract infections
Not every patient experiences these effects, and their severity can vary.
7. How to Use Acabrunat 100 mg
Take Acabrunat exactly according to the oncologist's prescription.
General administration information:
- Swallow the capsule whole with water.
- Do not crush, chew, or open the capsule.
- It may be taken with or without food according to the prescribed regimen.
- Take doses at the prescribed times and maintain a consistent schedule.
- Do not change the dose or stop treatment without consulting the treating doctor.
The exact dose and duration depend on the patient's cancer type, treatment history, response, other medicines, and medical condition.
8. How Acabrunat 100 mg Works
Acabrunat contains acalabrutinib, which inhibits Bruton’s tyrosine kinase (BTK).
BTK is an important component of B-cell receptor signaling. In certain blood cancers, this pathway contributes to malignant B-cell growth and survival. By inhibiting BTK, acalabrutinib interferes with these signaling processes and can help reduce the growth and survival of cancerous B cells.
9. Safety Advice
Because Acabrunat is a prescription anticancer medicine, treatment should be supervised by a qualified healthcare professional.
Important precautions:
- Inform your doctor about all prescription medicines, OTC medicines, vitamins, and herbal products you take.
- Tell your doctor if you have a history of bleeding problems, heart problems, liver disease, or infections.
- Acalabrutinib may increase the risk of bleeding; report unusual bruising or bleeding promptly.
- Tell your doctor about any planned surgery or dental procedure.
- Blood counts should be monitored because treatment can reduce blood-cell counts.
- Watch for signs of infection such as fever or persistent sore throat.
- Certain medicines can significantly alter acalabrutinib levels, so medication interactions must be reviewed by a healthcare professional.
- Antacids and acid-reducing medicines may require specific timing or management.
- Avoid grapefruit/grapefruit products unless your healthcare provider confirms they are appropriate with your treatment.
Important: Acabrunat should not be self-medicated or promoted as a general-purpose medicine. It is intended for appropriately diagnosed patients under specialist supervision.
10. Frequently Asked Questions
Q1. What is Acabrunat 100 mg Capsule?
Acabrunat 100 mg is a prescription anticancer medicine containing acalabrutinib, a BTK inhibitor used for certain B-cell blood cancers.
Q2. What is the active ingredient in Acabrunat?
The active ingredient is acalabrutinib 100 mg.
Q3. What cancers can Acabrunat be used for?
It is used for certain patients with CLL, SLL, and MCL, according to the applicable indication and treatment plan.
Q4. Is Acabrunat a chemotherapy medicine?
It is a targeted anticancer therapy, specifically a BTK inhibitor, rather than traditional cytotoxic chemotherapy.
Q5. Can I take Acabrunat without a prescription?
No. It should be used only under appropriate medical supervision.
Q6. What are common side effects?
Headache, diarrhea, fatigue, muscle/joint pain, anemia, neutropenia, thrombocytopenia, and upper respiratory infections are among reported side effects.
Q7. Can Acabrunat interact with other medicines?
Yes. Acalabrutinib can interact with several medicines, including some CYP3A inhibitors/inducers and medicines that increase bleeding risk. Your healthcare provider should review your complete medication list.
Q8. How should Acabrunat be stored?
Follow the storage conditions printed on the product packaging. Some product information specifies storage at room temperature/below 30°C.
11. Substitutes for Acabrunat 100 mg
Medicines containing the same active ingredient, acalabrutinib 100 mg, may include:
- Calquence 100 mg Capsule – AstraZeneca
- Acaone 100 mg Capsule – MSN Laboratories
- Capbrusam 100 mg Capsule – Samarth Life Sciences
- Betatinib Capsule – Adley Formulations
However, a substitute should not be selected solely on the basis of the same strength. The treating oncologist or pharmacist should confirm that the alternative is appropriate for the patient's indication, treatment plan, and local regulatory requirements.
12. SEO & B2B Keywords
For Phoenix Exim – Nagpur, India, you can use the following buyer-intent and export-focused keywords:
- Acabrunat 100 mg Capsule exporter from India
- Acabrunat 100 mg supplier in India
- Acabrunat 100 mg wholesale supplier
- Acalabrutinib 100 mg capsule exporter
- Acalabrutinib 100 mg pharmaceutical supplier
- Acabrunat 100 mg wholesale exporter from Nagpur
- Acabrunat 100 mg capsules international supplier
- Acabrunat 100 mg medicine exporter India
- Acalabrutinib oncology medicine exporter India
- Acabrunat 100 mg B2B pharmaceutical supplier
- Acabrunat 100 mg supplier USA
- Acabrunat 100 mg supplier UK
- Acabrunat 100 mg supplier Australia
- Acabrunat 100 mg supplier Singapore
- Acabrunat 100 mg supplier Canada
- Acabrunat 100 mg supplier South Korea
- Acabrunat 100 mg supplier UAE
- Acalabrutinib 100 mg capsule wholesale India
- Acabrunat 100 mg oncology medicine supplier
- Acalabrutinib BTK inhibitor supplier India
- Acabrunat 100 mg pharmaceutical exporter Nagpur
- Acabrunat 100 mg international pharmaceutical trading
- Acalabrutinib cancer medicine supplier India
- Acabrunat 100 mg B-cell cancer medicine supplier
- Acabrunat 100 mg CLL medicine supplier
- Acabrunat 100 mg mantle cell lymphoma medicine supplier
- Acabrunat 100 mg SLL medicine exporter
- Natco Acabrunat 100 mg supplier India
- Acalabrutinib 100 mg export supplier Nagpur
- Phoenix Exim Acabrunat 100 mg exporter India
Keywords







